NCT00898963 2020-07-31
Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496
Eastern Cooperative Oncology Group
Completed
Clinical Trials
9 trialsNCT01563861 2019-12-20
S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma
SWOG Cancer Research Network
Completed
NCT00667017 2018-12-14
RFT5-dgA Immunotoxin in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma
University of Texas Southwestern Medical Center
Phase 2 Terminated
NCT00389818 2018-06-06
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma
AIDS Malignancy Consortium
Phase 2 Completed
NCT01150643 2017-05-17
Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab
Eastern Cooperative Oncology Group
Completed
NCT00896922 2017-02-28
S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911
SWOG Cancer Research Network
Completed
NCT01366170 2016-05-19
Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma
Children's Oncology Group
Completed
NCT01366157 2016-05-17
Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma
Children's Oncology Group
Completed
NCT00430053 2012-03-15
Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma
National Institutes of Health Clinical Center (CC)
Completed